2BBBullish & Bearish
Health Care

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Score & Signals

Rhythm Pharmaceuticals, Inc. (RYTM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 57 out of 100.

2BB score and signals

Rhythm Pharmaceuticals, Inc.’s current 2BB score is 57 out of 100, built from the signal categories below.

SignalScoreReading
Activity69High
Momentum65Improving
Financial strength37Weak
Quality96Very Strong
Risk39Low

Company facts

HeadquartersBoston, Massachusetts, United States
FoundedNov 2008
Employees414
52-week range$74.51 – $122.20

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-24—-0.6874—$100.26M
2026-11-02—-0.7311—$85.65M
2026-08-04-0.73-0.8376$71.26M$68.62M
2026-05-05-0.83-0.8697$60.11M$56.89M